Sign in
4

Changes in Ownership

Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-22-048471

Chief Operating Officer acquired 7,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nabulsi Azmi Chief Operating Officer 2022-09-01 Grant or award +7,500 41,971 D
Loading xslF345X03/doc4.xml…